Information:
Error:
ID
31471
Description
Immune Response Following Treatment of Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence; ODM derived from: https://clinicaltrials.gov/show/NCT01147536
Link
https://clinicaltrials.gov/show/NCT01147536
Keywords
Versions (1)
- 8/26/18 8/26/18 -
Copyright Holder
Agenus Inc.
Uploaded on
August 26, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Renal Cell Carcinoma NCT01147536
Eligibility Renal Cell Carcinoma NCT01147536
- StudyEvent: Eligibility
Similar models
Eligibility Renal Cell Carcinoma NCT01147536
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
histological confirmation of renal cell carcinoma
Item
confirmation of histological diagnosis of rcc with evidence of >/= 25% clear cell carcinoma
boolean
C0449575 (UMLS CUI [1,1])
C0007134 (UMLS CUI [1,2])
C0007134 (UMLS CUI [1,2])
AJCC tumor staging intermediate risk for recurrence
Item
ajcc tnm tumor stage at intermediate risk for recurrence
boolean
C0441915 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C3640764 (UMLS CUI [1,3])
C0034897 (UMLS CUI [1,4])
C3258246 (UMLS CUI [1,2])
C3640764 (UMLS CUI [1,3])
C0034897 (UMLS CUI [1,4])
Availability of cancer vaccines
Item
at least 8 doses of vaccine available from patient's tumor
boolean
C0376659 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
C0470187 (UMLS CUI [1,3])
C0920425 (UMLS CUI [1,2])
C0470187 (UMLS CUI [1,3])
Life expectancy
Item
life expectancy of at least 3 months
boolean
C0023671 (UMLS CUI [1])
ECOG performance status
Item
ecog ps of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Concomitant cardiovascular diseases, NYHA class
Item
cardiovascular disease status of nyha class less than 2
boolean
C0007222 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C1275491 (UMLS CUI [1,2])
Adequate hematopoietic, renal and hepatic function
Item
adequate hematopoietic, renal and hepatic function
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0541533 (UMLS CUI [3])
C0232804 (UMLS CUI [2])
C0541533 (UMLS CUI [3])
negative Infection status of hiv, htlv-1, hbsag, anti-hcv-ab
Item
negative serology tests for hiv, htlv-1, hbsag, anti-hcv-ab
boolean
C0481430 (UMLS CUI [1])
C0020094 (UMLS CUI [2,1])
C1513916 (UMLS CUI [2,2])
C0919711 (UMLS CUI [3])
C0853904 (UMLS CUI [4])
C0020094 (UMLS CUI [2,1])
C1513916 (UMLS CUI [2,2])
C0919711 (UMLS CUI [3])
C0853904 (UMLS CUI [4])
Pregnancy
Item
females must have negative pregnancy test
boolean
C0427780 (UMLS CUI [1])
Metastatic or residual renal cell carcinoma
Item
evidence of metastatic or residual rcc
boolean
C0278678 (UMLS CUI [1])
C0007134 (UMLS CUI [2,1])
C0543478 (UMLS CUI [2,2])
C0007134 (UMLS CUI [2,1])
C0543478 (UMLS CUI [2,2])
Radiology: Enlargement of lymph nodes
Item
documented radiological enlarged lymph nodes
boolean
C0497156 (UMLS CUI [1,1])
C0043299 (UMLS CUI [1,2])
C0043299 (UMLS CUI [1,2])
Pregnancy or breast feeding
Item
females who are pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Use of post-operative experimental drug
Item
use of any other investigational product from 4 weeks post-surgery
boolean
C0304229 (UMLS CUI [1,1])
C2112579 (UMLS CUI [1,2])
C2112579 (UMLS CUI [1,2])
Splenectomy performed during nephrectomy
Item
splenectomy performed during nephrectomy
boolean
C0037995 (UMLS CUI [1,1])
C0027695 (UMLS CUI [1,2])
C0027695 (UMLS CUI [1,2])